-
Erythropoietin (EPO) Drugs Market Forecast To Surge USD 12.5 Billion By 2033, Driven By 5.20% CAGR
07 Feb 2025 09:58 GMT
… resources to maintain significant shares through innovative drug formulations … resources to maintain significant shares through innovative drug formulations … Celltrion Inc.
•Hospira Inc.
•Watson Pharmaceuticals
•GlycoMimetics Inc.
•Akebia Therapeutics
…
-
Generic drugmaker Endo 2018 forecast disappoints, shares drop
27 Feb 2018 15:00 GMT
… and increased competition, sending its shares down nearly 5 percent in … Plc’s (AGN.N) unit, Watson Pharmaceuticals Inc, to delay launching a … 8 percent.
The company’s shares were down 4.7 percent …
-
Watson Pharmaceuticals To Buy Arrow Group For $1.75 Billion
17 Jun 2009 23:14 GMT
… 17, 2009 (FinancialWire) — Watson Pharmaceuticals, Inc. (NYSE: WPI) said it … of around 16.9 million shares of Watson common stock valued … ;p>Corona, California-based Watson Pharmaceuticals is engaged in the development …
-
Pharmaceutical and Biotechnology Royalty Rates Report and Directory 2024: Technology Licensed, License Fees, Upfront and Milestone Payments for Deals Signed Since 2020 - ResearchAndMarkets.com
13 Mar 2024 13:11 GMT
…
2.2. How do revenue shares figure?
2.3. A review … Pharmaceuticals
VYNE Therapeutics
Vyrix Pharmaceuticals
Watson Pharmaceuticals
WAVE Life Sciences
Wigen Biomedicine …
-
Chronic Liver Diseases Therapeutics Market to See Growth 2024-2031 | Astellas Pharma ,Bristol-Myers Squibb, Sanofi S.A
19 Jan 2024 14:12 GMT
… Inc., Takeda Pharmaceutical, Valeant Pharmaceuticals, Watson Pharmaceuticals, Inc., Theratechnologies Inc., Alnylam Pharmaceuticals … employed to determine their market shares. All percentage share splits and …